Compare Jubilant Pharmova with Glenmark Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

JUBILANT PHARMOVA vs GLENMARK PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    JUBILANT PHARMOVA GLENMARK PHARMA JUBILANT PHARMOVA /
GLENMARK PHARMA
 
P/E (TTM) x 13.0 13.7 95.1% View Chart
P/BV x 1.9 2.1 92.3% View Chart
Dividend Yield % 0.9 0.5 181.7%  

Financials

 JUBILANT PHARMOVA    GLENMARK PHARMA
EQUITY SHARE DATA
    JUBILANT PHARMOVA
Mar-21
GLENMARK PHARMA
Mar-21
JUBILANT PHARMOVA /
GLENMARK PHARMA
5-Yr Chart
Click to enlarge
High Rs1,047573 182.8%   
Low Rs251195 128.6%   
Sales per share (Unadj.) Rs559.1387.8 144.2%  
Earnings per share (Unadj.) Rs51.834.4 150.5%  
Cash flow per share (Unadj.) Rs80.150.1 159.9%  
Dividends per share (Unadj.) Rs5.002.50 200.0%  
Avg Dividend yield %0.80.7 118.3%  
Book value per share (Unadj.) Rs297.6249.6 119.2%  
Shares outstanding (eoy) m159.28282.17 56.4%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x1.21.0 117.2%   
Avg P/E ratio x12.511.2 112.3%  
P/CF ratio (eoy) x8.17.7 105.7%  
Price / Book Value ratio x2.21.5 141.7%  
Dividend payout %9.77.3 132.9%   
Avg Mkt Cap Rs m103,365108,353 95.4%   
No. of employees `000NANA-   
Total wages/salary Rs m21,72823,437 92.7%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m89,055109,439 81.4%  
Other income Rs m298502 59.4%   
Total revenues Rs m89,354109,941 81.3%   
Gross profit Rs m18,69921,289 87.8%  
Depreciation Rs m4,5164,436 101.8%   
Interest Rs m2,4733,531 70.0%   
Profit before tax Rs m12,00813,825 86.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m3,7644,124 91.3%   
Profit after tax Rs m8,2449,701 85.0%  
Gross profit margin %21.019.5 107.9%  
Effective tax rate %31.329.8 105.1%   
Net profit margin %9.38.9 104.4%  
BALANCE SHEET DATA
Current assets Rs m29,52573,596 40.1%   
Current liabilities Rs m10,48842,010 25.0%   
Net working cap to sales %21.428.9 74.1%  
Current ratio x2.81.8 160.7%  
Inventory Days Days137 188.6%  
Debtors Days Days3486 39.2%  
Net fixed assets Rs m58,10967,093 86.6%   
Share capital Rs m159282 56.4%   
"Free" reserves Rs m47,24870,148 67.4%   
Net worth Rs m47,40770,430 67.3%   
Long term debt Rs m25,64038,888 65.9%   
Total assets Rs m87,634140,689 62.3%  
Interest coverage x5.94.9 119.1%   
Debt to equity ratio x0.50.6 98.0%  
Sales to assets ratio x1.00.8 130.6%   
Return on assets %12.29.4 130.0%  
Return on equity %17.413.8 126.2%  
Return on capital %19.815.9 124.9%  
Exports to sales %00-   
Imports to sales %10.20-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs m9,117NA-   
Fx inflow Rs m11,20735,753 31.3%   
Fx outflow Rs m9,11712,023 75.8%   
Net fx Rs m2,09023,729 8.8%   
CASH FLOW
From Operations Rs m17,84311,312 157.7%  
From Investments Rs m-7,390-6,752 109.4%  
From Financial Activity Rs m-17,094-4,418 386.9%  
Net Cashflow Rs m-7,289278 -2,619.9%  

Share Holding

Indian Promoters % 46.5 46.7 99.7%  
Foreign collaborators % 4.2 0.0 -  
Indian inst/Mut Fund % 24.2 35.0 69.1%  
FIIs % 23.1 25.9 89.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 49.3 53.4 92.5%  
Shareholders   113,776 329,870 34.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare JUBILANT PHARMOVA With:   SUN PHARMA    LUPIN    CIPLA    AUROBINDO PHARMA    DR. REDDYS LAB    



Today's Market

Hero MotoCorp's Investment in Ather Energy, UltraTech Cement Quarterly Results, and Buzzing Stocks Today(Pre-Open)

Indian share markets ended on a positive note yesterday. Benchmark indices ended with marginal gains in a choppy session supported by auto stocks.

Related Views on News

JUBILANT PHARMOVA 2020-21 Annual Report Analysis (Annual Result Update)

Nov 8, 2021 | Updated on Nov 8, 2021

Here's an analysis of the annual report of JUBILANT PHARMOVA for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of JUBILANT PHARMOVA . Also includes updates on the valuation of JUBILANT PHARMOVA .

GLENMARK PHARMA 2020-21 Annual Report Analysis (Annual Result Update)

Sep 6, 2021 | Updated on Sep 6, 2021

Here's an analysis of the annual report of GLENMARK PHARMA for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of GLENMARK PHARMA. Also includes updates on the valuation of GLENMARK PHARMA.

Sun Pharma vs Dr Reddy's: Which is Better? (Views On News)

Dec 16, 2021

In an extremely competitive market, two pharma companies are competing against each other to grab the top spot.

5 Stocks to Watch Out for Amid the Omicron Outbreak (Views On News)

Dec 3, 2021

As the new variant of Covid-19 emerges, keep an eye on these stocks.

This Stock Just Made a Historical Debut on the Exchanges (Views On News)

Nov 15, 2021

Shares of the company listed at premium of 253% from its IPO price, the highest ever.

More Views on News

Most Popular

India's Best Semiconductor Stocks(Views On News)

Jan 7, 2022

Modern wars are fought with semiconductors. India's best semiconductor stocks have big tailwinds from defence and manufacturing.

10 Indian Companies with the Fastest Growth in Dividend Payouts...(Views On News)

Jan 10, 2022

These companies have been consistently paying higher dividends for several years.

Tata Steel vs SAIL: Which Stock is Better?(Views On News)

Jan 13, 2022

With government initiatives set to boost the steel sector, find out who has a better chance of coming out on top.

Looking for Consistent Compounding Stocks? Here's a Watchlist for You(Views On News)

Jan 6, 2022

These companies have generated mind boggling returns for investors over the years.

Watch Out for these 4 Indian Companies Betting Big on EV Supply Chain(Views On News)

Jan 11, 2022

The upside in supply chain players could be huge but a delay in the transition to EVs, or any policy related hiccups could end the momentum.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

JUBILANT PHARMOVA SHARE PRICE


Jan 17, 2022 (Close)

TRACK JUBILANT PHARMOVA

  • Track your investment in JUBILANT PHARMOVA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON JUBILANT PHARMOVA

JUBILANT PHARMOVA 5-YR ANALYSIS

COMPARE JUBILANT PHARMOVA WITH

MARKET STATS